ADC Therapeutics
company
Exit Type
IPO
Exit Date
May 14, 2020
Exit parties in this round
| Partner | Fund Round | Return Amount | Return Multiplier | |
|---|---|---|---|---|
| AstraZeneca | Series E | — | — | Detail |
